isirv Antiviral Group
Cameron Wolfe, Duke University Medical Centre, Durham, NC, USA
Dr. Cameron Wolfe is a Professor of Medicine, in the Transplant Infectious Diseases Division at Duke University, in Durham, North Carolina.
Cameron maintains an active clinical practice in transplant and HIV medicine, and during the pandemic has led the Duke Health System and University COVID taskforces, trying to respond to the pandemic. He has been an investigator for multiple interventional inpatient and outpatient Covid19 treatment and prophylactic trials, and currently sits as a member of the NIH COVID19 Treatment Guidelines committee. His principal area of clinical research is in safety and availability of organ donation, and respiratory viral disease in the immunosuppressed host.
Cameron is a faculty member of the Duke Human Vaccine Institute, and serves as clinical lead for management of emerging biothreats or the university. This role has led him to be in charge of university response to such issues as ebola, zika, covid, and most recently mpox. He holds an Adjunct Instructor role at The University of North Carolina, Chapel Hill. He holds advisory roles in the NIH-funded Duke Vaccine and Treatment Evaluation Unit, has served as a vaccine safety monitor for CDC-sponsored vaccine studies of COVID-19 and influenza vaccination, as well as a number of other NIAID-funded research programs, in emerging infections, HIV and HCV transplantation.
